Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Самообучение с помощью КОМПЬЮТЕРА для улучшения исполнительной функции (COMPEX)

29 сентября 2026 г. обновлено: Hanne Christensen, Bispebjerg Hospital

Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer

Обзор исследования

Подробное описание

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.

Тип исследования

Интервенционный

Регистрация (Оцененный)

307

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

      • Copenhagen, Дания
        • Rigshospitalet
      • Copenhagen, Дания
        • Bispebjerg Hospital

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

От 18 лет до 100 лет (Взрослый, Пожилой взрослый)

Принимает здоровых добровольцев

Нет

Полы, имеющие право на обучение

Все

Описание

Inclusion Criteria:

  • A diagnose of stroke, cardiac arrest or Parkinson's disease.
  • Aged 18 years or older.
  • Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
  • Computer and internet access at home.
  • Providing informed consent.

Inclusion criteria specific for stroke

  • Inclusion within 6 months post-stroke
  • Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
  • Initial stroke severity >/= NIHSS 3.

Inclusion criteria specific for cardiac arrest

• Inclusion within 6 months post ictus.

Inclusion criteria specific for Parkinson's disease

  • Clinical diagnosis of PD.
  • Anti-parkinsonian medical treatment (dopaminergic or other).

Exclusion Criteria:

  • Informed consent not provided
  • Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
  • Not able to participate according to investigator

Exclusion criteria specific for stroke

  • Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
  • Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.

Exclusion criteria specific for cardiac arrest • None

Exclusion criteria specific for PD

• Diagnosis of PD Dementia according to the MDS PD Dementia criteria

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Уход
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Одинокий

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Specific computer-based cognitive rehabilitation

154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions.

CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.

Активный компаратор: General computer-based cognitive stimulation

154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities.

For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
CABPad Working Memory Test
Временное ограничение: After the end of the intervention (8 weeks after baseline)

Test of working memory. The higher score the better (theoretically infinite score)

After the end of the intervention (8 weeks after baseline)

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
CABPad Working Memory Test - 3 months follow-up
Временное ограничение: At follow-up visit 3 months after end of intervention

Test of working memory. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after end of intervention
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

At follow-up visit 3 months after the end of the intervention
Trail Making A
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making A
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Trail Making B
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making B
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
SDMT
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
SDMT
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Phonological verbal fluency test
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Phonological verbal fluency test
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Categorical verbal fluency test
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Categorical verbal fluency test
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Fear questionnaire
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

Directly after the intervention, eight weeks after inclusion
Fear questionnaire
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

At follow-up visit 3 months after the end of the intervention
mrs: Modified Rankin Scale
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
mrs: Modified Rankin Scale
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
EuroQol-5 domain (EQ-5D-5L)
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner

Directly after the intervention, eight weeks after inclusion
EuroQol-5 domain (EQ-5D-5L)
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner

At follow-up visit 3 months after the end of the intervention
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
Compliance
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Monitoring of total time spent training in minutes

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Временное ограничение: At follow-up visit 3 months after the end of the intervention

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
2) visual analogue scale (1-10)
Временное ограничение: Directly after the intervention, eight weeks after inclusion

After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more.

Directly after the intervention, eight weeks after inclusion
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Временное ограничение: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

Directly after the intervention, eight weeks after inclusion

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Публикации и полезные ссылки

Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

1 июня 2020 г.

Первичное завершение (Оцененный)

5 ноября 2026 г.

Завершение исследования (Оцененный)

5 февраля 2027 г.

Даты регистрации исследования

Первый отправленный

3 января 2020 г.

Впервые представлено, что соответствует критериям контроля качества

13 января 2020 г.

Первый опубликованный (Действительный)

14 января 2020 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

2 октября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

29 сентября 2026 г.

Последняя проверка

1 сентября 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕ РЕШЕНО

Описание плана IPD

This is currently undecided

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться